Introduction
The nucleus tractus solitarius (NTS) is known to play a major role in the regulation of cardiovascular, respiratory, gustatory, hepatic and swallowing functions (Jean 2001; Lawrence and Jarrott, 1996) . The NTS appears to be not just a simple 'relay' nucleus, but performs complex integration of information from multiple synaptic inputs of both peripheral and central origins.
The calcitonin gene-related peptide (CGRP) is a 37-amino-acid peptide that was initially described as being generated by alternative splicing of the calcitonin gene (Amara, et al., 1982) . CGRP is found in neurons of the CNS and thought to play a role in many neuronal functions, including the control of blood pressure (Raynaud and Cohen, 1994 ). It has been described that CGRP mRNA is expressed in neurons of the nodose ganglia and petrosal ganglia (Czyzyk-Krzeska, et al., 1991) and CGRP immunoreactive terminals project from those ganglia to the NTS (Torrealba, 1992) . Furthermore, hypotension and bradycardia were observed after CGRP injection in the NTS (Vallejo, et al., 1988) , which suggests involvement of the peptide in central cardiovascular control.
Evidence that the level of CGRP decreased in brain areas related to blood pressure control in spontaneously hypertensive rats (SHR) has also been obtained (Lewis et al., 6 1990) . It is thought that decreased CGRP in the SHR can be restored after local nerve growth factor administration, which has triggered a fall in blood pressure in test animals (Supowit, et al., 2001) . These features further indicate that CGRP plays a role in the central mechanism related to blood pressure control.
Adrenomedullin (ADM) is a 52-amino-acid peptide originally isolated from a human pheochromocytoma (Kitamura, et al., 1993) . It is structurally and functionally related to CGRP, belonging to the amylin peptide family (McDonald, et al., 1994) . ADM has been shown to be widely involved in the control of fluid and electrolyte homeostasis and cardiovascular function through peripheral and central nervous system (CNS) activity.
Voltage-dependent Ca 2+ channels (VDCCs) serve as crucial mediators of membrane excitability and Ca 2+ -dependent functions such as neurotransmitter release, enzyme activity, and gene expression. The modulation of VDCCs is believed to be an important means of regulating Ca 2+ influx and thus has a direct influence on many Ca 2+ dependent processes. Modulation of VDCCs by CGRP and ADM in various types of cells has been described previously (Nakazawa, et al., 1992; Ono, et al., 1989; Zhang, et al., 2007) .
However, the effect of CGRP and ADM on VDCCs in the NTS has not yet been clarified, and little is known about signaling pathways in the NTS. Consequently, the purpose of this study is to investigate the effects of CGRP and ADM on VDCC current (ICa) in the 7 NTS.
Results

CGRP-and ADM-induced facilitation of IBa
An example of CGRP-and ADM-induced facilitation of IBa is shown in Fig. 1 . IBa was emitted every 20 sec with a 100 msec depolarizing voltage step, up to 0 mV from a holding potential of -80 mV. As shown in Fig. 1A -D, application of 1 μM CGRP and ADM rapidly and reversibly facilitated IBa. The current-voltage relationship measured before and during application of CGRP (1 μM) and ADM (1 μM) are shown in Fig. 1E and F, respectively. From a holding potential of -80 mV, IBa was activated after -40 mV with a peak current amplitude at 0 mV. Neither CGRP nor ADM altered the current-voltage relationship (n＝5).
The concentration-response relationship in the CGRP-and ADM-induced facilitation of IBa is shown in Fig. 2A . Application of 1 nM-10 μM CGRP and ADM rapidly and reversibly facilitates IBa without changing current kinetics. To generate a concentration-response curve, CGRP and ADM concentrations were applied randomly, 8 and each neuron was exposed to only a single concentration. Fig 
Pharmacological characterization of CGRP-and ADM-induced facilitation of IBa
In the next series of experiments, we analyzed the effects of CGRP and ADM on IBa in neurons treated with selective antagonists. These receptors are characterized by their selective antagonists, namely CGRP(8-37) fragment for the CGRP receptor and ADM(22-52) for the ADM receptor (Chiba, et al., 1989; Eguchi, et al., 1994) . As shown in In contrast to SQ22536 and PKI(5-24) , in neurons treated with U-73122 (a membrane-permeable aminosteroid which blocks phosphatidylinositol-specific PLC, 10 μM for 15 min) (5, 39), GF109203X (a selective PKC inhibitor, 10 μM for 30 min) and PD98,059 (a MAPK tyrosine kinase inhibitor, 10 μM for 2 min) did not attenuate the CGRP-induced facilitation of IBa. These results suggest that CGRP facilitates VDCCs involving AC and PKA pathways in the NTS neurons (Fig. 5) .
To evaluate the possible contribution of MAPK tyrosine kinase to the ADM-induced facilitation of IBa, the effects of ADM on IBa in neurons treated with PD98,059 were investigated. In six neurons tested, treatment with PD98,059 (10 μM for 2 min) attenuated the ADM-induced facilitation of IBa.
In contrast to PD98,059, in neurons treated with U-73122, GF109203X, SQ22536 and PKI(5-24) in the recording pipette did not attenuate the ADM-induced facilitation of IBa.
These results suggest that ADM facilitates VDCCs involving MAPK pathways in NTS neurons (Fig. 5) .
Characterization of VDCC subtypes in CGRP-and ADM-induced facilitation of IBa 12
It has been reported that several different types of VDCCs, such as L-, N-, P-, Q-and R-type VDCCs exist in the NTS (Rhim and Miller, 1994) . We previously demonstrated in the NTS that the mean percentages of IBa-L, IBa-N, IBa-P/Q and IBa-R of total IBa were 35.7, 28.7, 19.3 and 16.0%, respectively (Endoh, 2006) . L-type VDCCs are blocked by nifedipine. N-type VDCCs are blocked by ω-CgTx GⅥA. P/Q-types VDCCs are blocked by ω-Aga ⅣA. Despite the addition of all these blockers, a component of current that is resistant still remains and has been termed R-type (Endoh, 2004) .
Thus, the types of HVA VDCCs which are facilitated by CGRP and ADM were then investigated. When nifedipine (10 μM, Nif; L-type VDCC blocker) ＋ ω-Aga ⅣA (1 μM, P/Q-type VDCC blocker) and Nif ＋ ω-CgTx GⅥA (1 μM, N-type VDCC blocker) were applied first, resistant IBa was not significantly facilitated by a subsequent application of CGRP and ADM. On the other hand, when ω-CgTx GⅥA ＋ ω-Aga ⅣA was applied first, resistant IBa were facilitated by the subsequent application of CGRP and ADM. These results demonstrate that CGRP and ADM facilitates L-type VDCCs, without significantly affecting N-and P/Q-types VDCCs in NTS neurons (Fig. 6) . (Smith, et al., 2002) . Although ADM is known to bind CGRP receptors with low affinity (Aiyar, et al., 1996) , CGRP does not bind ADM receptors (Owji, et al., 1996; Owji, et al., 1995) .
In addition, we could demonstrate that CGRP facilitates VDCCs involving AC and PKA. ADM facilitates VDCCs involving MAPK in the NTS. cAMP-PKA pathways are coupled to ADM receptors in various types of cells (Kitamura, et al., 1993; Shimekake, et al., 1995; Ross and Yallampalli, 2006) , including neural cells (Xu and Krukoff, 2005) .
Recently, it has been demonstrated that ADM enhances baroreceptor reflex response via cAMP-PKA in the NTS (Ho, et al., 2008) . We could previously demonstrate that MAPK-induced VDCCs facilitation is an important signaling in the NTS (Endoh, 2005; Endoh, et al., 2008) 
This study has shown that CGRP and ADM facilitate L-type VDCCs in the NTS.
Similar observation has been demonstrated in smooth muscle cells (Nakazawa, et al., 1992 ) and cardiac cells (Ono, et al., 1989) . There are several mechanisms of VDCCs facilitation (Dolphin, 1996) . L-type VDCCs facilitation can result from a strong conditioning depolarization that recruits 'silent channels' (Artelejo, et al., 1990 ).
Alternatively, L-type VDCCs can be facilitated by protein kinases. L-type VDCCs possess several consensus PKA and PKC phosphorylation sites and physiological studies have demonstrated channel facilitation by these enzymes (McDonald, et al., 1994) . In contrast, in rat ventricular myocytes, ADM inhibits L-type VDCCs (Zhang, et al., 2007) . These differences in effect of ADM on VDCCs may depend on the cell type.
What is the physiological relevance of CGRP and ADM-induced facilitation of VDCCs? Microinjection of CGRP into the NTS area induces hypotension and bradycardia (Vallejo, et al., 1988) . In contrast, microinjection of ADM into the NTS area elevates arterial pressure and heart rate (Cui, et al., 2008) . In this study, we could demonstrate that both CGRP and ADM facilitate L-type VDCCs in the NTS. However, their effects on cardiovascular parameters were opposite. The exact mechanisms by which CGRP and ADM produce increasing or decreasing responses in the NTS are unknown. It should be noted that neuronal networks exist within the NTS. NTS neurons can be divided into two groups, GABAergic and glutamatergic (Mifflin and Felder, 1990; Brooks, et al. 1992 In the case of glutamatergic neurons, the effect would be opposite. Microinjection of ADM into the NTS increases cardiovascular function. It can be considered that facilitation of VDCCs on glutamatergic neurons can enhance glutamate release and therefore increase cardiovascular function. In addition, we could not rule out the fact 16 that the NTS expresses Ca 2+ -activated K + channels (Tell and Bradley, 1994) , which can hyperpolarize the membrane (Halliwell, 1990; Hille, 1981) . In this study, identification of distinct NTS subgroups was not possible.
In conclusion, the present data shows that CGRP facilitates L-type VDCCs via the Gα NTS neurons in neonatal rats were acutely dissociated as previously reported (Endoh, 2005) . Young Wistar rats (7-18 days old) were decapitated and their brains were quickly removed and submerged in ice cold artificial cerebrospinal fluid (aCSF) of the following composition (in mM): NaCl 126, NaHCO3 26.2, NaH2PO4 1, KCl 3, MgSO4 1.5, CaCl2 1.5 and glucose 30; pH 7.4 and saturated with 95% O2 and 5% CO2. Thin transverse slices from brainstems, 400 μm in thickness, were prepared by a tissue slicer (DTK-1000; Dosaka EM Co., Ltd, Kyoto, Japan). After being sectioned, 3-5 slices obtained from a single brain were transferred to a holding chamber and stored in oxygenated aCSF at room temperature for at least 40 min before use. Slices were then transferred to a conical tube containing gently aerated aCSF at 36 ℃ to which 1.8 U/ml dispase (grade Ⅰ; 0.75 ml/slice) was added. After incubation for 60 min, slices were rinsed with enzyme-free aCSF. Under a dissecting microscope, the NTS region was micropunched and placed on a poly-l-lysine-coated coverslip. The cells were then dissociated by trituration using progressively smaller diameter pipettes and allowed to settle on a coverslip for 20 min.
Whole-cell patch-clamp recordings 18
Voltage-clamp recordings were conducted using the whole-cell configuration of the patch-clamp technique (Hamill, et al., 1981) . Fabricated recording pipettes (2-3 MΩ)
were filled with an internal solution of the following composition (in mM): 100 CsCl, 1 MgCl2, 10 HEPES, 10 BAPTA, 3.6 MgATP, 14 Tris2phosphocreatine (CP), 0.1 GTP, and 50 U/ml creatine phosphokinase (CPK). pH was adjusted to 7.2 with CsOH. After antibodies were purchased from Upstate biotechnology (Lake Placid, NY, U.S.A.). All antibodies were derived from rabbits immunized with a synthetic peptide corresponding to the COOH-terminal sequence of the human Gαi, Gαs and Gαq/11, respectively. U-73122 was purchased from Wako Pure Chemical Industries (Osaka, Japan). 
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